Reports for EMTRICITABINE
Ingredient
EMTRICITABINE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 300MG 200MG | TABLET | Resolved | 2022-08-15 | 2022-10-24 | 166805 |
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2020-04-16 | 2020-05-08 | 112370 |
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Actual shortage | 2025-01-23 | 2025-01-23 | 248436 |
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
TEVA-EMTRICITABINE/TENOFOVIR | 300MG 200MG | TABLET | Actual shortage | 2025-01-23 | 2025-02-20 | 248439 |
TEVA-EMTRICITABINE/TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2022-04-21 | 2023-06-21 | 159201 |
TEVA-EMTRICITABINE/TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 128004 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
Showing 1 to 1 of 1